GoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q4 EPS of $0.07, $0.02 better than the analyst estimate of $0.05. Revenue for the quarter came in at $184.1 million versus the consensus estimate of $178.67 million.

For earnings history and earnings-related data on GoodRx Holdings, Inc. (GDRX) click here.